Literature DB >> 2104974

Enterococcal sepsis in neonates: features by age at onset and occurrence of focal infection.

S R Dobson1, C J Baker.   

Abstract

Fifty-six neonates with enterococcal septicemia in a single hospital from 1977 through 1986 were studied. The incidence was low and constant until 1983, when an increase, attributable to infections in infants older than 7 days of age (late-onset), was noted. These infants were more premature (mean gestational age 29.5 vs 36.9 weeks) and had lower birth weights (mean 1250 vs 2700 g) than those with early-onset enterococcal sepsis, and in most the infections were characterized by a nosocomial origin. Infants with early-onset infection had a mild illness with respiratory distress typical of other etiologic agents or diarrhea without focal infection. By contrast, late-onset enterococcal sepsis was heralded by severe apnea, bradycardia, circulatory collapse, and increased ventilatory requirements. Focal infections, including scalp abscess or catheter-related infection (23% each), meningitis or pneumonia (15% each), were common. Rapid clinical improvement and clearance of bacteremia resulted from therapy with an aminoglycoside and either ampicillin or vancomycin, but only if abscesses were drained and intravascular catheters were removed. Mortality rates for early-onset, late-onset, and necrotizing enterocolitis-associated infection were 6, 8, and 17%, respectively. Enterococcus is a frequent cause of late-onset septicemia in premature neonates, and empiric therapy should include appropriate antimicrobial agents.

Entities:  

Mesh:

Year:  1990        PMID: 2104974

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

1.  Very late onset infections in the neonatal intensive care unit.

Authors:  James L Wynn; Daniel K Benjamin; Daniel K Benjamin; Michael Cohen-Wolkowiez; Reese H Clark; P Brian Smith
Journal:  Early Hum Dev       Date:  2011-09-15       Impact factor: 2.079

2.  Enterococcus faecium meningitis.

Authors:  D P Barker; P W Buss; N Marlow; N M Brown; M R Millar
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

3.  Contribution of antibody to neutrophil-mediated killing of Enterococcus faecalis.

Authors:  M J Gaglani; C J Baker; M S Edwards
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

Review 4.  Antibacterial resistance.

Authors:  Jocelyn Y Ang; Elias Ezike; Basim I Asmar
Journal:  Indian J Pediatr       Date:  2004-03       Impact factor: 1.967

Review 5.  Neonatal infectious diseases: evaluation of neonatal sepsis.

Authors:  Andres Camacho-Gonzalez; Paul W Spearman; Barbara J Stoll
Journal:  Pediatr Clin North Am       Date:  2013-01-17       Impact factor: 3.278

6.  Endocarditis in neonatal intensive care unit.

Authors:  A Rastogi; J A Luken; R S Pildes; D Chrystof; F LaBranche
Journal:  Pediatr Cardiol       Date:  1993-07       Impact factor: 1.655

7.  Contributions of complement and immunoglobulin to neutrophil-mediated killing of enterococci.

Authors:  B S Harvey; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

8.  Bacterial isolates of early-onset neonatal sepsis and their antibiotic susceptibility pattern between 1998 and 2004: an audit from a center in India.

Authors:  Ramesh Bhat Y; Leslie Edward S Lewis; Vandana K E
Journal:  Ital J Pediatr       Date:  2011-07-11       Impact factor: 2.638

9.  Incidence, clinical characteristics and attributable mortality of persistent bloodstream infection in the neonatal intensive care unit.

Authors:  Jen-Fu Hsu; Shih-Ming Chu; Chiang-Wen Lee; Pong-Hong Yang; Reyin Lien; Ming-Chou Chiang; Ren-Huei Fu; Hsuan-Rong Huang; Ming-Horng Tsai
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

10.  Ampicillin and gentamicin are a useful first-line combination for the management of sepsis in under-five children at an urban hospital in Bangladesh.

Authors:  Samira Bibi; Mohammod Jobayer Chisti; Farhana Akram; Mark A C Pietroni
Journal:  J Health Popul Nutr       Date:  2012-12       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.